X
Pharma Advancement
  • Home
  • Articles
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development
    Avadel Pharmaceuticals Receives

    Avadel Pharmaceuticals Receives Orphan Drug Designation from FDA for LUMRYZ™ (sodium oxybate) for Extended-Release Oral Suspension for the Treatment of Idiopathic Hypersomnia

    Robots and AI in Drug

    Robots and AI in Drug Discovery Are Transforming Medicine

    Stringent Policy around COVID Vaccines Laid by FDA

    Stringent Policy around COVID Vaccines Laid by FDA

    Pharmaceutical-Chemicals Market Booms with Rising API Demand

    Pharmaceutical Chemicals Market Booms with Rising API Demand

    Next in Pharma 2025 Innovations

    Next in Pharma 2025: Innovations Shaping the Future

    Work Smart: Go for Hands-Free Lab Informatics at the Bench, Not Scribbled Notes and Delayed Documentation at Your Desk

    Clinical Development

    AI Revolutionizing Drug Discovery and Clinical Development

    Drug-Development

    China’s Super Me-Too Drug Development: A New Pharma Frontier

    Omics Based Clinical Trials

    Asia Pacific Omics-Based Clinical Trials Market Growth

  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us
No Result
View All Result
  • Home
  • Articles
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development
    Avadel Pharmaceuticals Receives

    Avadel Pharmaceuticals Receives Orphan Drug Designation from FDA for LUMRYZ™ (sodium oxybate) for Extended-Release Oral Suspension for the Treatment of Idiopathic Hypersomnia

    Robots and AI in Drug

    Robots and AI in Drug Discovery Are Transforming Medicine

    Stringent Policy around COVID Vaccines Laid by FDA

    Stringent Policy around COVID Vaccines Laid by FDA

    Pharmaceutical-Chemicals Market Booms with Rising API Demand

    Pharmaceutical Chemicals Market Booms with Rising API Demand

    Next in Pharma 2025 Innovations

    Next in Pharma 2025: Innovations Shaping the Future

    Work Smart: Go for Hands-Free Lab Informatics at the Bench, Not Scribbled Notes and Delayed Documentation at Your Desk

    Clinical Development

    AI Revolutionizing Drug Discovery and Clinical Development

    Drug-Development

    China’s Super Me-Too Drug Development: A New Pharma Frontier

    Omics Based Clinical Trials

    Asia Pacific Omics-Based Clinical Trials Market Growth

  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us
No Result
View All Result
Pharma Advancement
No Result
View All Result
Home Drug Development Research & Development

NEX China 2016 to Set Sail by the “Healthy and Natural” Wind

Yuvraj_pawp by Yuvraj_pawp
22nd February 2016
in Research & Development

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

NEX China 2016, hosted by UBM EMEA and China Chamber of Commerce of Medicines &Health Products Importers & Exporters and co-organized by UBM Sinoexpo, will be held on 21 – 23rd June 2016 at Hall E2 in Shanghai New International Expo Centre. As one of the crucial sectors presented at CPhI China, NEX China plays a vital role in supporting the export of natural extract manufacturing enterprises. Over the recent years, the event has become the first choice to do business for many natural extracts manufacturers and other similar companies.

Export of plant extracts achieved the growth rate of 29.6% year on year throughout January-June 2015 reaching USD 1.09 billion. This industry has become one of the fastest growing industries in TCM product export. Furthermore, the future extract market can be described as full of opportunities, with the application areas of plant extracts constantly being expanded, the emerging markets slowly rising, and the concept of people returning to nature strengthened. “Lead the industry innovation, co-create a healthy future”-“NEX China” will make every effort to provide a trade and exchange platform helping professional buyers in pharmaceutical, health product, food and cosmetics industries.

The exhibition site in 2016 will gather more than 500 professional plant extract enterprises from all over the world, the industry’s latest products and innovative technologies, constituting a 16,000m2 of SNIEC area. This exhibition will serve as the best platform for extract suppliers to showcase new products, exchange new technologies, and establish cooperation with quality buyers from China and foreign countries. There will be plenty of exhibits on the site to contribute to the wonderfulness: wherein, Chongqing Joywin will showcase its advantageous product: inulin; Layn Natural Ingredients will bring its featured product siraitiagrosvenorii extract. In innovative technology, Xi’an Honson Biotechnology will display the nebulization extraction and separation technology newly researched and developed; Xi’an Changyue will show its supercritical method for extracting serenoaserrulata fruit. Those diversified new products and leading technologies will certainly make NEX China a brilliant journey in June 2016 with fruitful results for its participants.

Online visitor registration is now open! Please visit http://www.cphi.com/china to register or contact Ms. Tina Zheng (tina.zheng@ubmsinoexpo.com) for more information.

Previous Post

Grasp the opportunity at Emerging Markets for High Growth of Life Science and Chemical Instrumentation

Next Post

P-Logi to Lead Pharmaceutical Enterprises into a New Era of Developed Logistics

Related Posts

Robots and AI in Drug
Articles

Robots and AI in Drug Discovery Are Transforming Medicine

29th May 2025
Pharmaceutical-Chemicals Market Booms with Rising API Demand
Asia

Pharmaceutical Chemicals Market Booms with Rising API Demand

28th May 2025
Next in Pharma 2025 Innovations
Articles

Next in Pharma 2025: Innovations Shaping the Future

28th May 2025
Insights

Work Smart: Go for Hands-Free Lab Informatics at the Bench, Not Scribbled Notes and Delayed Documentation at Your Desk

27th May 2025
Insights

AstraZeneca Eyes Acquisition To Develop Cell Therapies

24th March 2025
Drug Development

Continuous Bioprocessing Market to Surge by 2028

7th March 2025
Next Post
Italian pharmaceutical R & D excellence presented at the 33rd Congress of the European Association of Urology

P-Logi to Lead Pharmaceutical Enterprises into a New Era of Developed Logistics

Qucik Links

  • Drug Development
  • Manufacturing
  • News
  • Events & Conferences
  • Newsletter Archive
Pharma Advancement

About Us

Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.

Subscribe Us

System

  • Search
  • Sitemap
  • RSS Feed

Resources

  • Advertise with us
  • Contact Us
  • Download Mediapack
  • Newsletters Archive

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

No Result
View All Result
  • Home
  • Articles
  • Drug Development
  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

Login to your account below

Forgotten Password?

Fill the forms bellow to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In